Shares of Amgen Inc. AMGN slipped 1.37% to $272.05 Thursday, on what proved to be an all-around positive trading session for ...

It’s been 19 months since Amgen completed its $27.8 billion acquisition of Horizon Therapeutics, and the California company ...

Some research has shown that dividend-paying stocks significantly outperformed their non-dividend-paying peers over the past ...

Amgen on Thursday said its first-quarter profit rose 24%, handily exceeding Wall Street expectations, as product sales ...

We came across a bullish thesis on Amgen Inc. (AMGN) on Substack by Magnus Ofstad. In this article, we will summarize the ...

Amgen has announced a significant expansion of the Ohio manufacturing facility in the US, with an investment of $900m.

Amgen's diverse portfolio ensures stability, but risks like high debt and biosimilar competition loom. Check out my look at ...

The stable outlook reflects S&P Global Ratings’ expectation that Amgen’s revenue and EBITDA will remain stable despite patent ...

Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Investors with a lot of money to spend have taken a bearish stance on Amgen (NASDAQ:AMGN). And retail traders should know. We noticed this today when the trades showed up on publicly available ...